Effect of Weikangning on gastric cancer cell growth and expression of vascular endothelial growth factor and its receptors KDR and Flt-1

被引:2
作者
Li, Qing-Ming [1 ]
Kan, Fang-Ju [2 ]
Min, Cun-Yun [2 ]
机构
[1] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Integrat Tradit Chinese Med, Affiliated Hosp 2, Guangzhou 510120, Guangdong, Peoples R China
[2] Sun Yat Sen Univ, Affiliated Hosp 2, Dept Tradit Chinese Med, Guangzhou 510120, Guangdong, Peoples R China
关键词
Weikang-ning; Gastric cancer; VEGF; KDR; Flt-1; MGC-803;
D O I
10.3748/wjg.v11.i7.938
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
AIM: To observe the effect of Chinese traditional herbal decoction Weikang-ning (WKN) on cell growth and expression of VEGF and its receptors KDR and Flt-1 in gastric cancer cell line MGC-803. METHODS: A total of 120 male Wistar rats were divided into control group, high dose, medium dose and low dose groups fed with natural saline, 20, 10, and 5 g/kg of WKN, respectively. The experimental animals were finally killed for the preparation of drug-containing serum. The gastric cancer cell MGC-803 was cultured with the drug-containing serum drawn from the rats in different groups. We observed the growth condition of the cancer cells with light microscope and flow cytometer. The expression of mRNA of VEGF and its receptors KDR and Flt-1 was detected with RT-PCR. RESULTS: The proportion of cells in G(0)-G(1) phase was (65.40 +/- 0.41)%, (56.92 +/- 0.62)%, (55.89 +/- 0.69)% in high, medium and low dose groups respectively vs (41.35 +/- 0.55)% in control group (P<0.01), while the cells in G(2)-S and S phases were (11.62 +/- 0.62)% and (22.99 +/- 0.69)%, (17.08 +/- 0.80)% and (26.00 +/- 0.71)%, (19.37 +/- 0.57)% and (24.74 +/- 0.64)% in high, medium and low dose groups, respectively, vs (23.65 +/- 0.56)% and (35.00 +/- 0.60)% in control group (P<0.01). The expression of mRNA of VEGF and its receptors was significantly decreased, the area of electrophoresis bands (AREA), the absorptivity of mean optical density (A) and the product of AREA and A were significantly lower in WKN-administered groups than that in control group (P<0.01). CONCLUSION: The decoction of WKN suppresses the growth of gastric cancer cell MGC-803 and decreases the expression of mRNA of both VEGF and its receptors KDR and Flt-1. (C) 2005 The WJG Press and Elsevier Inc. All rights reserved.
引用
收藏
页码:938 / 942
页数:5
相关论文
共 50 条
[41]   Plasma levels of vascular endothelial growth factor (VEGF) and its receptor, Flt-1, in haematological cancers: A comparison with breast cancer [J].
Belgore, FM ;
Lip, GYH ;
Bareford, D ;
Wadley, M ;
Stonelake, P ;
Blann, AD .
AMERICAN JOURNAL OF HEMATOLOGY, 2001, 66 (01) :59-61
[42]   Expression of vascular endothelial growth factor isoforms and their receptors Flt-I, KDR, and neuropilin-I in synovial tissues of rheumatoid arthritis [J].
Ikeda, M ;
Hosoda, Y ;
Hirose, S ;
Okada, Y ;
Ikeda, E .
JOURNAL OF PATHOLOGY, 2000, 191 (04) :426-433
[43]   Autocrine motility factor secreted by tumor cells upregulates vascular endothelial growth factor receptor (FLT-1) expression in endothelial cells [J].
Funasaka, T ;
Haga, A ;
Raz, A ;
Nagase, H .
INTERNATIONAL JOURNAL OF CANCER, 2002, 101 (03) :217-223
[44]   Characterization of the extracellular domain in vascular endothelial growth factor receptor-1 (Flt-1 tyrosine kinase) [J].
Tanaka, K ;
Yamaguchi, S ;
Sawano, A ;
Shibuya, M .
JAPANESE JOURNAL OF CANCER RESEARCH, 1997, 88 (09) :867-876
[45]   Flt-1 (Vascular Endothelial Growth Factor Receptor-1) Is Essential for the Vascular Endothelial Growth Factor-Notch Feedback Loop During Angiogenesis [J].
Chappell, John C. ;
Mouillesseaux, Kevin P. ;
Bautch, Victoria L. .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2013, 33 (08) :1952-1959
[46]   Gene therapy for pancreatic cancer using an adenovirus vector encoding soluble flt-1 vascular endothelial growth factor receptor [J].
Hoshida, T ;
Sunamura, M ;
Duda, DG ;
Egawa, S ;
Miyazaki, S ;
Shineha, R ;
Hamada, H ;
Ohtani, H ;
Satomi, S ;
Matsuno, S .
PANCREAS, 2002, 25 (02) :111-121
[47]   Modulation of human NK cell lines by vascular endothelial growth factor and receptor VEGFR-1 (FLT-1) [J].
Chen, WS ;
Kitson, RP ;
Goldfarb, RH .
IN VIVO, 2002, 16 (06) :439-445
[48]   Vascular endothelial growth factor (VEGF) and soluble VEGF receptor FLT-1 in diabetic nephropathy [J].
Kim, NH ;
Oh, JH ;
Seo, JA ;
Lee, KW ;
Kim, SG ;
Choi, KM ;
Baik, SH ;
Choi, DS ;
Kang, YS ;
Han, SY ;
Han, KH ;
Ji, YH ;
Cha, DR .
KIDNEY INTERNATIONAL, 2005, 67 (01) :167-177
[49]   Expression of vascular endothelial growth factor (VEGF) and its receptors in human neuroblastoma [J].
Meister, B ;
Grünebach, F ;
Bautz, F ;
Brugger, W ;
Fink, FM ;
Kanz, L ;
Möhle, R .
EUROPEAN JOURNAL OF CANCER, 1999, 35 (03) :445-449
[50]   In Vitro Expression of Vascular Endothelial Growth Factor and Its Receptors by Placental Macrophages [J].
Pavlov, O. V. ;
Sheveleva, T. S. ;
Selkov, S. A. .
BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE, 2012, 153 (02) :222-225